COVID-19 vaccine contract size by region 2021

As of the end of March 9, 2021, India has secured a total of some 2.2 billion COVID-19 vaccine doses through contracts. The European Union made pre-purchase agreements for nearly 1.84 billion doses in total with various manufacturers. This statistic shows the size of COVID-19 vaccine contracts based on total number of doses secured by countries. However, the overwhelming majority of these doses have yet to be produced and delivered.

Countries and regions with the largest COVID-19 vaccine contracts as of March 2021 (in million doses)

Characteristic	Number of doses in millions
India	2,200
European Union	1,835
United States	1,210
Covax	700
United Kingdom	417
Japan	314
Indonesia	301
Brazil	300
China	300
Canada	238
Mexico	211
Russia	160
Latin America bloc	150
South Korea	130
Australia	125
Turkey	105
Pakistan	88
Malaysia	75
Middle East bloc	75
Uzbekistan	70
Philippines	67
Thailand	63
Egypt	50
Nepal	50
Other	369

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

March 2021

More information

Region

Worldwide

Survey time period

as of March 9, 2021

Supplementary notes

Including vaccines already approved or on track to be approved.
When country contracts include a range of doses to be purchased, we count the lower number. On Dec. 23, Canada’s contracts were updated to reflect those details verified by the government.The Latin America bloc covers all countries in the region except Brazil. The European Union bloc represents the 27 countries of the European Union. The Covax agreement extends to most countries in the world, including many in Africa that wouldn’t otherwise be covered. Jurisdictions without a population figure, such as Somalia and Syria, have been omitted. The Middle East bloc covers U.A.E., Egypt, Bahrain and Jordan. Partnerships involving local manufacturers are listed under the original vaccine developer.

Citation formats